| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
16,927 |
14,721 |
$2.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,474 |
10,161 |
$811K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,982 |
4,397 |
$746K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,609 |
1,009 |
$420K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,237 |
1,117 |
$215K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,705 |
4,159 |
$170K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,013 |
1,700 |
$94K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,836 |
1,624 |
$90K |
| 80053 |
Comprehensive metabolic panel |
12,264 |
10,696 |
$90K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
157 |
144 |
$88K |
| 71045 |
Radiologic examination, chest; single view |
3,724 |
3,322 |
$85K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,080 |
2,781 |
$80K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,290 |
2,678 |
$67K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,848 |
1,668 |
$65K |
| 85027 |
|
12,302 |
10,873 |
$59K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,856 |
2,510 |
$49K |
| 71046 |
Radiologic examination, chest; 2 views |
1,018 |
881 |
$38K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
563 |
478 |
$34K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
808 |
634 |
$32K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,536 |
1,340 |
$29K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
775 |
664 |
$26K |
| 84484 |
|
2,687 |
2,273 |
$20K |
| 81025 |
|
2,304 |
2,065 |
$16K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
726 |
632 |
$14K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
40 |
38 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
155 |
96 |
$9K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
171 |
134 |
$9K |
| 74022 |
|
138 |
131 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
317 |
274 |
$9K |
| 81003 |
|
5,704 |
5,012 |
$9K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
314 |
273 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
314 |
273 |
$9K |
| 83690 |
|
1,588 |
1,426 |
$8K |
| 81001 |
|
3,021 |
2,546 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,319 |
1,065 |
$6K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
60 |
55 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,409 |
4,723 |
$5K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
15 |
14 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
201 |
189 |
$5K |
| 87081 |
|
675 |
603 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
630 |
561 |
$4K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
12 |
$4K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
28 |
28 |
$4K |
| 72100 |
|
103 |
93 |
$4K |
| 83880 |
|
154 |
141 |
$3K |
| 82553 |
|
480 |
410 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,859 |
3,345 |
$3K |
| 82150 |
|
568 |
517 |
$3K |
| 87420 |
|
186 |
170 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
447 |
398 |
$2K |
| 84702 |
|
246 |
206 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
89 |
80 |
$2K |
| 82550 |
|
587 |
501 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
109 |
95 |
$2K |
| 59025 |
Fetal non-stress test |
44 |
29 |
$2K |
| 83735 |
|
404 |
363 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
75 |
69 |
$1K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
352 |
257 |
$1K |
| 73564 |
|
16 |
16 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
15 |
15 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
546 |
415 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
686 |
594 |
$1K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
24 |
12 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,633 |
3,726 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
207 |
190 |
$938.98 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13 |
12 |
$916.75 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
73 |
67 |
$882.71 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
14 |
$840.20 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
17 |
12 |
$822.45 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13 |
12 |
$641.28 |
| 85379 |
|
73 |
68 |
$626.31 |
| 80050 |
General health panel |
15 |
14 |
$546.48 |
| 85610 |
|
215 |
192 |
$533.75 |
| 73562 |
|
19 |
15 |
$520.96 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
85 |
77 |
$488.19 |
| 86850 |
|
161 |
134 |
$456.11 |
| 86803 |
|
39 |
34 |
$430.96 |
| 73610 |
|
16 |
13 |
$426.24 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
243 |
217 |
$393.95 |
| 86787 |
|
39 |
34 |
$388.98 |
| 86762 |
|
31 |
26 |
$319.46 |
| 86592 |
|
78 |
72 |
$256.19 |
| 87340 |
|
33 |
28 |
$249.98 |
| 86900 |
|
170 |
141 |
$221.54 |
| 86901 |
|
168 |
140 |
$221.54 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
12 |
12 |
$216.86 |
| 87210 |
|
40 |
38 |
$193.05 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
30 |
29 |
$182.30 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
31 |
25 |
$180.16 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
122 |
106 |
$145.62 |
| J2704 |
Injection, propofol, 10 mg |
3,416 |
2,771 |
$126.51 |
| 82950 |
|
31 |
26 |
$119.71 |
| 86140 |
|
26 |
24 |
$98.42 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
13 |
12 |
$78.16 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
41 |
39 |
$58.19 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,445 |
1,239 |
$47.12 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,135 |
986 |
$40.75 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
104 |
87 |
$15.66 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
190 |
110 |
$15.47 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
26 |
18 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
14 |
13 |
$0.00 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
36 |
26 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
21 |
12 |
$0.00 |
| 80320 |
|
14 |
12 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
14 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
13 |
12 |
$0.00 |